Navigation

dexamethasone ophthalmic (Maxidex)

 

Classes: Corticosteroids, Ophthalmic

Dosing and uses of Maxidex, AKDex (dexamethasone ophthalmic)

 

Adult dosage forms and strengths

ophthalmic suspension

  • 0.1%

 

Inflammatory Ocular Conditions

Solution

  • 1-2 gtt in conjunctival sac q1hr during day and q2hr at night, THEN
  • Decrease to 1 gtt q4-6hr, THEN
  • Decrease to 1 gtt q6-8hr

Suspension

  • 1-2 gtt in conjunctival sac q4-6hr; in severe cases may use as in soluiton

 

Pediatric dosage forms and strengths

Safety and efficacy not established

 

Maxidex, AKDex (dexamethasone ophthalmic) adverse (side) effects

Frequency not defined

Cataract (4% )

Ocular hypertension

Open-angle glaucoma, optic nerve damage, and defects in visual acuity and field of vision (after prolonged use)

 

<1%

Transient ocular stinging, burning, local irritation, ocular discharge, ocular discomfort or pain, foreign body sensation, hyperemia, abnormal vision/blurring, pruritus, lid margin crusting, sticky sensation, increased fibrin, dry eye, conjunctival edema, corneal staining, keratitis, tearing, edema, irritation, corneal ulcer, browache, eyelid erythema, corneal edema, infiltrate, corneal erosion, mydriasis, ptosis, epithelial punctate keratitis, and possible corneal or scleral malacia, [posterior subcapsular cataracts] (prolonged use)

 

Warnings

Contraindications

Hypersensitivity

Glaucoma, epithelial defect

Viral diseases including epithelial herpes simplex keratitis, acute infectious stages of vaccinia, varicella, and other diseases of cornea & conjunctiva

Mycobacterial infection of eye, fungal diseases

 

Cautions

Avoid prolonged treatment, if possible, because of the ocular side effects of glaucoma, secondary infection (herpes simplex), cataract formations, etc

May mask infection or enhance existing infection

Reduce to lowest dose, use suspension last, wait 5min between gtts if using multiple drugs

Contact lenses should not be worn during treatment of ophthalmic infections

Perforations may occur in diseases that cause thinning of the cornea or sclera

 

Pregnancy and lactation

Pregnancy category: C

Lactation: Excretion in milk unknown/use caution

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Maxidex, AKDex (dexamethasone ophthalmic)

Mechanism of action

Inhibits the inflammatory response to mechanical, chemical, or immunologic agents

Corticosteroids inhibit edema, fibrin deposition, capillary dilatation, and migration of leukocytes and phagocytes in the acute inflammatory response